No company in this industry has share. That is not a rhetorical flourish; it is the structural fact that determines everything else about how the competitive landscape behaves.
BASF, the largest chemical company in the world by revenue outside the Chinese state-owned complex, reported sales of EUR 59.7 billion in 2025. At an average 2025 rate of EUR/USD 1.136 that is USD 67.8 billion, or 1.22% of a USD 5,550 billion market. Dow reported net sales of USD 40.0 billion, or 0.72%. Put the two largest Western chemical companies together and they hold less than two percentage points of the market between them. A top-ten list in this industry accounts for a low single-digit fraction of the whole, and the reason is arithmetic: the market is not a market in the antitrust sense. It is several hundred product markets that happen to share a feedstock base.
Concentration in chemicals exists at the product level. In commodity olefins a single world-scale cracker can matter to a regional balance. In a specialty additive, three or four producers can hold most of the supply. But there is no participant whose position in ethylene gives it pricing power in polyurethane catalysts, and no participant whose position in coatings gives it leverage over naphtha. The competitive landscape is therefore not one landscape. It is four, and they do not compete on the same axis.
SABIC, Sinopec, ExxonMobil Chemical, Dow, LyondellBasell, the Gulf national champions and increasingly the large Chinese private refiners. Their position rests on molecule ownership at the wellhead or the refinery gate. They win or lose on feedstock differential and on operating rate, and they are structurally long the commodity end of the chain. Dow's 2025 numbers show what that means in a down-cycle: operating EBIT of USD 0.4 billion on USD 40.0 billion of sales, a margin of 1.0%, against USD 2.6 billion the year before - a fall of 84.6%. Cash from operations halved to USD 1.1 billion. The company still paid USD 1.5 billion of dividends.
This is the archetype most exposed to the capacity wave described elsewhere in this report, and the one with the least room to do anything about it. When Dow idles a cracker in Europe, the Middle East, Africa and India, as it did during 2025, that is not a strategic retreat. It is an admission that the marginal barrel of merchant olefin in that region does not cover cash cost.
BASF, INEOS, Covestro, Evonik, Clariant, Solvay and the Verbund sites they operate. The defining asset is not a plant but an integration: a cracker whose by-products become the next unit's feedstock, whose waste heat runs the next unit, and whose logistics are pipelines rather than trucks. Verbund economics are genuinely superior - which is why BASF's EBITDA before special items margin of 11.1% in 2025 was eleven times Dow's operating margin on a far more diversified base.
But Verbund economics are a defence against operating inefficiency, not against energy price. Cefic's 2025 Facts and Figures reports European gas prices still three times US levels and capacity utilisation 9.5% below the 2014-2019 pre-crisis average. A Verbund is a machine for turning cheap energy into many products at once; when energy is not cheap, integration multiplies the cost rather than diluting it.
BASF's response is instructive and unromantic. Between December 2023 and December 2025 it cut senior executives by 11% and reduced headcount by roughly 4,800, excluding about 1,000 recruited at the new Zhanjiang site in China over the same period. EUR 937 million of special charges were booked in 2025 for restructuring, primarily for the Ludwigshafen programme. The cluster is being made smaller, not fixed.
Wanhua, Reliance, PTT Global Chemical, Formosa, Hanwha, LG Chem, and behind them the Chinese state-owned majors. Their competitive logic is different again: they are instruments of industrial policy as much as commercial entities, they are financed at a cost of capital no Western peer can match, and their capacity decisions are made partly for strategic reasons. China now accounts for 46% of global chemical sales according to Cefic - roughly USD 2.55 trillion, more than three times Europe's 13%.
This is where the surplus is being manufactured. China is adding 7-8 Mtpa of ethylene and roughly 6 Mtpa of polyethylene in 2026, netting more than 4.0 Mtpa of new ethylene and derivatives capacity even after closures. The evident consequence is already visible in trade flows: Chinese polypropylene imports have fallen sharply from 2020 levels while exports keep rising, and those volumes are reaching North and Southeast Asia, Africa and Latin America.
DuPont, Croda, the post-divestiture parts of the old ICI and Hoechst inheritance, and a long tail of formulators. These businesses are genuinely differentiated on application knowledge and qualification cycles rather than on molecules, and they are the only archetype earning a defensible margin in the current cycle. The catch is that they are small. Specialty chemicals are 27% of the market in this report's segmentation and grow at 3.9% - fast enough to take share of value, nowhere near large enough to absorb the capital and people leaving the commodity end.
The competitive variable that matters most is not market share. It is survival of the cost position, and the industry has started to resolve it by exit rather than by price war. Cefic and Roland Berger count 37 Mt of announced European capacity closures over 2022-25, about 9% of the region's chemical capacity, affecting roughly 20,000 direct jobs. Half of the petrochemical tonnage is nine steam crackers - a net 16% reduction in European cracking capacity. Energy cost competitiveness is cited in 49% of the closure decisions, demand in 19%, overcapacity in 9% and regulation in 8%.
That is a competition being settled by balance sheet and by geography, not by product. The companies that win the next five years will be the ones with feedstock advantage in the Gulf and North America, policy support in China and India, or an application franchise defensible enough to price through a surplus. Companies that have none of the three will keep doing what BASF and Dow did in 2025: shrink the asset base, book the charge, and hold the dividend.
" value_chain_content: "The chemical value chain is usually drawn as five boxes: feedstock, cracker, derivatives, formulation, customer. The useful version of that diagram makes a blunter point. From naphtha to polymer pellet, this is a feedstock arbitrage with a service business bolted onto the end. Almost every margin question in the industry reduces to which of those two things a company is actually doing.
Two routes dominate. Steam cracking of naphtha produces ethylene and propylene together with a broad slate of C4s, aromatics and pygas; it is flexible in product mix and expensive in energy. Steam cracking of ethane produces mostly ethylene, cheaply, but leaves the cracker with almost nothing else to sell. The choice between them is not technical preference - it is a bet on the relative price of oil and gas that a company then has to live with for twenty years.
North American crackers built on shale ethane in the 2010s were built on that bet and won it. European crackers built on naphtha mostly lost it, and Cefic now reports European gas at three times US levels. That single differential, more than any management decision, explains why nine European steam crackers representing a net 16% of the region's cracking capacity have been announced for closure.
The Gulf sits in a third position: associated gas and ethane at a cost that no other region can replicate, with the political economy of a state that wants industrial diversification rather than maximum molecule margin. SABIC's competitive position is a function of the Saudi feedstock allocation, not of its operating excellence.
A cracker does not make one product. It makes a slate, and the economics of the whole unit depend on what the minor products are worth. Ethylene is the headline; propylene, butadiene, benzene, toluene, xylenes and pygas are the credits that decide whether the unit is profitable. When the C4 and aromatic markets are weak, the ethylene cash cost rises even if ethylene itself is unchanged.
This is why integrated complexes beat standalone ones and why the industry's cost curves are not smooth. It also explains a counterintuitive feature of the current cycle: producers with the most diversified slate are the ones most able to keep running through a trough, because some co-product somewhere is still covering its marginal cost. That is Verbund economics, and it is real. It is also not enough - BASF booked EUR 937 million of restructuring charges in 2025, primarily for Ludwigshafen, despite having the best-integrated site in Europe.
Between the cracker and the customer sit the derivative units - polyethylene, polypropylene, ethylene oxide and glycols, vinyls, styrenics, acrylates, oxo alcohols. This is where the majority of the industry's tonnage is converted and where the surplus is felt most directly. China's addition of more than 4.0 Mtpa of net new ethylene and derivatives capacity in 2026 lands almost entirely in this stage, and the effect is a compression of the derivative-to-feedstock spread rather than a fall in volume.
Dow's fourth-quarter 2025 disclosure is the cleanest available measurement of that compression: net sales down 9% year on year, local price down 8%, volume down only 2%. In other words roughly four-fifths of Dow's revenue decline came from price, not from selling less. For the full year the company reported a GAAP net loss of USD 2.4 billion against income of USD 1.2 billion in 2024, and operating EBIT of USD 0.4 billion against USD 2.6 billion.
Above the derivative units the chain changes character. Formulation - coatings, adhesives, sealants, lubricant additives, personal care actives, crop protection formulations, water treatment programmes - is not an arbitrage on feedstock. It is a service business: technical support, qualification against a customer's specification, regulatory documentation, and a switching cost measured in months of requalification rather than in dollars per tonne.
This is where margin survives. It is also why specialty chemicals, at 27% of this market, grow at 3.9% while basic chemicals and petrochemicals, at 42%, grow at 2.6%. The service layer is not immune to the cycle; it is simply not priced off naphtha.
Between the producer and the small customer sits a distributor layer that most market reports ignore and that carries a meaningful share of the physical flow - Brenntag, Univar Solutions, Azelis and a long regional tail. Distributors exist because the industry's customer base is fragmented and its order sizes are not: a formulator buying four drums does not want a producer relationship, and a producer does not want a four-drum order. The distributor's margin is a logistics and working-capital spread, and it is remarkably stable through the cycle precisely because it is not a molecule margin.
The pattern across the whole chain is consistent. Value accrues where the number of substitutes is lowest. That is the feedstock position in the Gulf, the qualification in a formulated specialty, and the specification in a regulated application. It does not accrue in the middle, where a commodity pellet is a commodity pellet and the buyer's only question is the delivered price of the next 5,000 tonnes.
Which is the reason the industry's strategic language is so uniform. Every announced initiative in this sector - circular feedstocks, bio-based intermediates, low-carbon cracking, digital customer interfaces - is an attempt to move a business out of the middle of this chain and into one of the ends. The 37 Mt of European closures is the same movement performed by subtraction: if you cannot move up the chain, leave it.
" investment_activity_content: "The most consequential number in the chemical industry in 2026 is not a growth rate. It is EUR 1.5 billion.
That is the confirmed investment capex in the European chemical industry in 2025 year-to-date, according to Cefic's and Roland Berger's first European Closures and Investments Radar. In 2022 the same measure was EUR 7.6 billion. The decline is 80.3% in three years, and confirmed new capacity fell from 2.7 Mt in 2022 to 0.3 Mt in 2025 year-to-date - a fall of 86% in the final year alone. Cumulative confirmed investments across 2022-25 total 7 Mt, roughly 2% of European chemical production capacity, against 37 Mt of announced closures.
Read those two figures together and the investment story of this industry writes itself. Europe is not investing in chemicals. It is de-investing, at a ratio of roughly five tonnes of closure for every tonne of new capacity.
The 37 Mt total is distributed unevenly by segment: upstream petrochemicals 17.8 Mt (48%), basic inorganics 11.7 Mt (32%), polymers 5.4 Mt (15%) and specialty chemicals 2.0 Mt (5%). By country, Germany accounts for 8.8 Mt (25%) and the Netherlands for 7.2 Mt (20%), followed by the UK at 4.5 Mt, France at 3.9 Mt, Italy at 2.5 Mt, Belgium at 2.3 Mt and Spain at 1.6 Mt. Roughly 20,000 direct jobs are cited across the announcements.
The geographic concentration matters for how the capital cycle resolves. Germany and the Netherlands are not peripheral sites. They are the two most integrated chemical clusters in Europe, and the nine steam crackers in the closure count sit inside them. When a cracker leaves an integrated cluster, the derivative units around it lose their feedstock pipeline and start buying merchant molecule at merchant prices. Closures inside a Verbund have a multiplier that closures of standalone plants do not, and Cefic's own framing - that the affected crackers are all located in integrated clusters, putting those clusters under increasing pressure - is unusually direct for an industry association.
BASF's 2025 results show the pattern at company level. Capital expenditure including intangibles was EUR 4.3 billion in 2025 and is guided to EUR 3.4 billion in 2026 - a reduction of about a fifth in a single year. Free cash flow nonetheless improved to EUR 1.3 billion from EUR 0.7 billion, and 2026 guidance is EUR 1.5 to 2.3 billion. That is the arithmetic of a company funding itself by spending less, not by earning more: EBITDA before special items fell to EUR 6.6 billion from EUR 7.2 billion.
Where BASF is still spending is instructive. The Zhanjiang Verbund site in China was successfully started up during the year, and about 1,000 people were recruited there between December 2023 and December 2025, even as total headcount fell by roughly 4,800. The capital is following the demand, and the demand is in Asia. The company is also systematically unlocking value from standalone businesses - Surface Technologies, Agricultural Solutions, Coatings - which is portfolio monetisation rather than industrial investment. Net special income of EUR 1.3 billion in 2025, mainly Wintershall Dea reimbursements relating to expropriated Russian assets, flattered net income to EUR 1.6 billion and should not be read as operating improvement.
Dow's 2025 was a defensive capital programme rather than an investment one. The company reported having achieved well over half of more than USD 6.5 billion in near-term cash and cost support actions, including accelerated delivery of more than USD 400 million of savings under a USD 1 billion programme. Cash from continuing operations fell to USD 1.1 billion from USD 2.9 billion, and USD 1.5 billion of dividends were still paid. When a company's capital allocation priority is self-funding a dividend through a trough, growth capex is the residual.
Three destinations absorb almost all of the industry's genuine growth investment.
China, despite the policy. China is adding 7-8 Mtpa of ethylene and about 6 Mtpa of polyethylene in 2026, netting more than 4.0 Mtpa of new ethylene and derivatives capacity even after plant closures. The April 2026 programme from the industry ministry and six other departments to upgrade some outdated petrochemical plants and phase out others by 2029 is not a brake on this - it is a quality filter applied after the capacity has been committed. Prior-cycle investment decisions are locked in; policy can only decide which of them survive to 2029.
India, on import substitution. The ACC's 2026 outlook singles out India as the growth driver within Asia Pacific, with GDP growth forecast at 6.4% and petrochemical demand projected to climb sharply - prompting Indian producers to accelerate specialty chemicals capacity specifically to reduce reliance on imports. This is the one large market where new Western-aligned chemical capacity has a structural reason to exist: domestic demand growth plus a policy environment that rewards local supply.
The Gulf and North America, on feedstock. Projects here are justified by molecule cost rather than by market growth, and they are the only projects in the world that can underwrite a commodity cracker on a through-cycle basis. They also explain why the global capacity total keeps rising while the Western company capital total keeps falling: the two numbers are measuring different geographies.
The confirmed European investment that survives is not commodity. Of the capital committed in 2022-25, themes cluster around the battery value chain at EUR 1.9 billion (14%), emission reduction at EUR 1.9 billion (14%) and recycling at EUR 1.5 billion (11%). Belgium took 2.4 Mt (36%) of confirmed capacity, Germany 0.8 Mt (12%) and France 0.4 Mt (6%) - about 60% of the total.
That is a coherent picture. Europe is not building chemical capacity; it is building decarbonisation and circularity capability on top of a shrinking chemical base. Whether that is a strategy or a consolation depends entirely on whether the regulatory framework that justifies it survives contact with the competitiveness debate - which is the subject of the Regulatory Landscape section of this report.
Capital in this industry is no longer allocated to markets. It is allocated to cost positions. A company will build in China at Chinese feedstock and labour economics, in the Gulf at Gulf gas economics, and in India at Indian demand economics. It will not build in a region where gas costs three times the US benchmark, utilisation runs 9.5% below its own pre-crisis average, and the policy framework adds cost faster than it adds demand. The EUR 1.5 billion is what that decision looks like when it is counted.
" technology_innovation_content: "The chemical industry has no shortage of technology narratives. It has a shortage of technologies that change the cost of a tonne. Those are different things, and the gap between them explains why so much announced innovation has so little effect on a forecast.
Three frontiers are real, in ascending order of how much they matter to the 2033 number: digital and process intensity, electrified cracking, and circular carbon. Only the first earns money today.
The least glamorous frontier is also the most reliably profitable. A cracker is a large, continuous, energy-intensive furnace train, and small improvements in yield, run-length between decokes, and energy per tonne of product compound over a whole site. Artificial intelligence applied to process control - inferential sensors, advanced process control, real-time optimisation, predictive maintenance - is now genuinely deployed in this industry rather than piloted, because the payback is measured in months and requires no new molecule.
The evidence that this is the live frontier is in the efficiency data rather than the vendor material. Cefic reports the European chemical industry has improved its energy efficiency by 40% since 1990. That improvement was not delivered by a breakthrough technology. It was delivered by thousands of incremental process gains, and it is why European producers can still run at all with gas at three times the US price.
There is a strategic implication that gets missed. In a surplus market, the return on a process improvement accrues to the customer, not the producer, because price is set by the marginal cost of the least efficient producer still running. Yield gains raise the industry's output and lower the industry's price. That is good for chemical users and largely neutral for chemical makers - which is why process innovation in a trough is defensive rather than growth-generating.
Steam cracking is the sector's largest single point-source of CO2 and its hardest to abate, because the reaction heat comes from burning fossil fuel inside the furnace. Electrified cracking replaces the burners with electrically heated reactors, which allows the heat to be decarbonised if the electricity is.
The flagship demonstration is the eFurnace developed by BASF, SABIC and Linde, a 6 MW electrically heated steam cracker furnace integrated into an existing Verbund site at Ludwigshafen. Six megawatts is two orders of magnitude below a world-scale cracker, and that is the honest way to read it: the technology has been shown to work at demonstration scale, not at commercial scale, and the economics depend entirely on the price of low-carbon electricity relative to the price of gas.
That dependency is the whole story. European industrial electricity prices are not converging on US shale gas economics in this decade. An electrified cracker in a region with three-times-US gas and expensive power converts a feedstock disadvantage into a power disadvantage without removing it. The technology will be deployed first where electricity is cheap and carbon is priced - which, in this decade, means neither Europe nor the United States in volume.
The most capital-intensive frontier is chemical recycling: breaking plastic waste back to monomers or to a naphtha substitute so that it can be re-cracked. It is the industry's answer to both the packaging regulation and the reputational problem of plastic, and in 2026 it is still a rounding error in the tonnage.
European chemical recycling capacity at the start of 2026 comprises roughly 405,000 tonnes per year across fourteen pilot plants and three commercial facilities. Pyrolysis accounts for about 330,000 tonnes of that, glycolysis about 50,000 and methanolysis about 25,000. The three commercial plants are SABIC's Geleen unit in the Netherlands at 50,000 tonnes (online 2024), BASF's ChemCycling plant at Schwarzheide in Germany at 80,000 tonnes (online 2025), and OMV's ReOil unit in Vienna at 200,000 tonnes - the largest, online in the first quarter of 2026. Pilots include OMV Schwechat, Neste Porvoo, INEOS Cologne and Borealis Stenungsund.
Against European polymer production of roughly 55 million tonnes a year, 405,000 tonnes is less than 1%. It is instructive to put it beside mechanical recycling: mechanical PET recycling in the EU alone runs at about 1.8 million tonnes a year, roughly five times the entire chemical recycling total, because it costs 30-40% less and has a better energy balance.
Two structural constraints limit how fast this scales. The first is scale economics: chemical recycling needs roughly 50,000 tonnes a year or more at a single site to make sense, which excludes most local and specialty waste streams. The second is what the industry calls the mass balance problem. A plant producing 5,000 tonnes of pyrolysis oil feeds it into a cracker or refinery handling millions of tonnes, and the recycled content has to be allocated across the output by an accounting convention. The convention is defensible; the marketing claim built on it is frequently not.
The forecast in this report puts bio-based and green chemicals at 9.0% CAGR, the fastest segment in the market - and still only 6.1% of the total by 2033, up from 4.0%. That is the honest shape of the technology transition. It grows six times faster than the industry and remains a niche, because it starts from USD 222 billion and the industry starts from USD 5,550 billion.
The technologies that will matter to 2033 are not the ones with the best press. They are the ones that change the delivered cost of a tonne in a region that currently cannot compete: cheap low-carbon power for electrified cracking, waste feedstock logistics that work at 50,000 tonnes, and process control that squeezes another few points of yield out of assets already built. Everything else is optionality on a carbon price that does not yet exist at the level required to pay for it.
" market_risk_content: "The risks in this market are unusually easy to rank, because one of them dominates and the others are mostly ways for it to get worse. Structural overcapacity is the risk. Everything below it - trade defence, energy price, feedstock geopolitics, demand substitution - is a mechanism through which the surplus is transmitted into price.
The clearest measurement sits one step upstream in ethylene, where nameplate capacity is around 235 Mt against roughly 190 Mt of demand - a structural surplus of about 45 Mt, or roughly 19% of capacity. That is not a temporary cyclical gap. It is the arithmetic result of a decade of investment decisions in China, the Gulf and North America arriving at the same time as demand growth decelerated.
And it is still growing. China is adding a further 7-8 Mtpa of ethylene and roughly 6 Mtpa of polyethylene in 2026, netting more than 4.0 Mtpa of new ethylene and derivatives capacity even after plant closures. The "anti-involution" policy introduced in July 2024 was designed to discipline exactly this, and it has moderated output growth without forcing shutdowns. The April 2026 plan by the industry ministry and six other departments to upgrade some outdated plants and phase others out by 2029 is a serious instrument - but it is a 2029 instrument, and the tonnes are landing in 2026.
The transmission is straightforward. A surplus is cleared by price, and price in chemicals is set at the marginal cash cost of the producer with the lowest feedstock advantage. European and North American producers with naphtha or imported-ethane economics are the marginal producer. They pay for the surplus in margin, which is what BASF's EUR 686 million fall in EBITDA before special items and Dow's USD 2.2 billion fall in operating EBIT actually are.
2025 was the year the chemical industry stopped being able to model trade. The ACC reports that US chemical exports fell 2.0% in 2025 and are expected to fall a further 0.6% in 2026, while imports fell 4.4% to USD 129 billion and are expected to decline another 1.6%. Both are forecast to rebound in 2027 and 2028.
The mechanism is visible in the annual profile. ACC describes a burst of activity in the first part of 2025 from front-loading ahead of tariff announcements, followed by a dissipation of momentum as tariff uncertainty generated customer hesitation and inventories built up. US chemical production was up 3.2% year on year in the first quarter and finished the year up only 0.7%. That is a policy shock wearing the costume of a demand shock.
The second-order risk is trade defence. As Chinese polypropylene and polyethylene exports reach North and Southeast Asia, Africa and Latin America, the destination markets respond with anti-dumping actions. Each action raises the landed cost of the marginal tonne in that market while doing nothing about the global surplus, so the tonne moves to the next open market. The industry's protection is localised; its overcapacity is not.
Cefic reports European gas prices still three times US levels, and European capacity utilisation 9.5% below its 2014-2019 pre-crisis average. In the closures radar, energy cost competitiveness is cited as the primary rationale in 49% of closure decisions - more than twice the combined weight of demand (19%), overcapacity (9%) and regulation (8%).
This is the risk that has already materialised rather than the one to watch. Thirty-seven megatonnes of announced European closures, nine steam crackers and roughly 20,000 direct jobs are the realised loss. The forward risk is that the programme is incomplete: closures inside integrated clusters remove a pipeline, and the derivative units around a departed cracker become structurally uncompetitive even though nobody announced their closure. Some of the next wave will arrive without a press release.
Chemical margins are a spread, and both legs of the spread can move for reasons unrelated to chemicals. The 2025 Middle East escalation demonstrated the upper bound: Asian ethylene moved from roughly USD 702 per tonne in February to about USD 1,500 per tonne in late March as shipping through Hormuz was disrupted. That is a doubling of the feedstock leg in six weeks, and no producer can hedge it fully.
The opposite leg is exposed too. The US ethane export system that supplies European and Asian crackers is a small number of terminals and a single basin; a constraint there is a direct constraint on the operating rate of every ethane-based cracker outside the United States. And because the marginal producer sets the price, a feedstock squeeze harms the efficient producer's customers as well as the inefficient producer's margin.
The industry's answer to commodity surplus is to become specialty. The 2025 data should make anyone cautious about how durable that is. ACC reports US specialty chemical output up 4.3% in 2025 - then forecasts it down 0.2% in 2026, with coatings slowing from 8.4% growth to 0.4%. A category that swings from +4.3% to -0.2% in one year is tracking its customers' inventory cycle, not earning a structural premium.
The distinction that matters is qualification, not marketing. An additive that is written into a customer's specification has a switch cost. A "specialty" surfactant sold into a formulator that can requalify in six weeks does not. Only the first is a moat, and the industry consistently counts both as one.
More than 80% of basic and specialty chemicals are consumed by the industrial sector, so the industry's fortunes are largely the industrial production outlook wearing a different hat. In the US, ACC tracked growth in only nine of its 20 key chemistry end-use industries in 2025, with improvement to twelve expected in 2026. Automotive - where the average vehicle contains more than USD 4,400 of chemistry - is expected to see slightly lower US sales in 2026, and housing is expected to stay flat.
A market whose two largest end-use blocks are flat-to-down cannot generate the volume growth needed to absorb new capacity. That is the connection between the demand chapter and the price chapter, and it is the reason this report's baseline is 3.30% rather than the mid-single-digit rates that appear in vendor material.
The conservative path in this report - USD 6,788.6 billion by 2033 at 2.55% - is not a stress case. It is the baseline with the surplus clearing two years later than assumed, which is what happens if the European closure programme slips and China's 2029 phase-out list goes unenforced. That single deferral is worth USD 408.7 billion of 2033 value. The realistic downside is larger still, because a deferred recovery also defers the capital that would have been reinvested.
" regulatory_landscape_content: "The single most important regulatory fact about the global chemical industry in 2026 is a negative one. Chemicals are not in CBAM.
That statement is worth making explicitly because a great deal of material in this sector assumes the opposite. The Carbon Border Adjustment Mechanism's definitive regime applies from 1 January 2026, and its covered sectors are cement, iron and steel, aluminium, fertilisers, electricity and hydrogen. Organic chemicals, polymers and specialty chemicals - the overwhelming majority of the USD 5,550 billion market sized in this report - are outside the mechanism entirely.
Under the definitive regime, EU importers above a single mass-based threshold of 50 tonnes of CBAM goods must apply for the status of authorised CBAM declarant and buy CBAM certificates from the competent authority in their member state. The certificate price is set from the auction price of EU Emissions Trading System allowances, expressed in euro per tonne of CO2, calculated as a quarterly average during 2026 and a weekly average from 2027 onward. Importers declare embedded emissions and surrender certificates annually, and can deduct any carbon price already paid during production.
The regime was simplified and strengthened ahead of go-live by Regulation (EU) 2025/2083, which amended the original Regulation (EU) 2023/956. Its function is to replace the carbon leakage protection that covered sectors currently receive through free allocation of ETS allowances: as free allocation is phased out for steel, cement and aluminium producers, importers surrender correspondingly more certificates.
For a chemical company the exposure is therefore indirect but not trivial. Fertilisers are in scope, which captures ammonia and nitric acid production - a real product line for several European chemical majors. CBAM also interacts with electricity and hydrogen pricing, both inputs to chemical production. But the deliberate asymmetry is the point: a European steel producer faces a carbon cost that its import competitor also faces. A European cracker operator faces the ETS cost and its Middle Eastern or Chinese competitor faces nothing.
That asymmetry, not the absolute cost of carbon, is the industry's strongest policy complaint. It is also the reason the Commission's review of CBAM's scope is watched more closely in Ludwigshafen and Antwerp than in Brussels: extension to organic chemicals would remove the distortion, and extension would also raise the cost of every downstream European manufacturer that uses imported chemistry.
Inside Europe the binding constraint is not carbon, it is authorisation. REACH's registration, evaluation, authorisation and restriction machinery sets the cost of keeping a molecule on the market, and the direction of travel over the past five years has been toward broader, group-based restrictions rather than substance-by-substance decisions.
The clearest live example is the universal restriction proposal for per- and polyfluoroalkyl substances, which would cover a very large substance group across industrial uses including fluoropolymers, semiconductor processing and refrigerants. For a chemical producer, a group restriction of that breadth is not a compliance cost - it is a portfolio question, because the substitution work has to be done years before the restriction applies.
Against that, the Commission has moved REACH revision into a wider simplification agenda aimed explicitly at reducing reporting burden and shortening approval timelines. The two forces are pulling in opposite directions and both are real: the same administration is producing more restriction proposals and fewer administrative obligations. Companies should budget for the first and not bank on the second.
The Packaging and Packaging Waste Regulation, Regulation (EU) 2025/40, sits outside the chemical regulatory perimeter but has become one of its more consequential demand signals. Recycled-content obligations for packaging create a legislated market for recycled polymer, which is the commercial justification for the chemical recycling capacity discussed in the Technology Innovation chapter. When a regulation creates demand rather than removing supply, it is the only kind of environmental rule the industry actively lobbies for.
China. The regulatory lever is industrial rather than environmental in effect. The April 2026 programme from the industry ministry and six other departments will upgrade some outdated petrochemical plants and phase out others by 2029, using lists compiled by local governments, with annual rolling surveys of newly identified facilities from 2027. Separately, authorities plan to reduce oil refining capacity to bring the petrochemical supply-demand balance back into line. These are the most consequential chemical regulations in the world in the 2026-2030 window, and they are being written in Beijing rather than Brussels.
United States. The dominant regulatory variable is trade policy rather than chemical law. The ACC's own framing is that the US industry risks losing its competitive advantage through "unfair import competition and overregulation" - a statement that positions the trade and environmental agendas as one issue. TSCA administration continues, but the binding constraint on US chemical investment in this cycle is tariff uncertainty, not registration.
India. The regulatory agenda is expansionary. With GDP growth forecast at 6.4% in 2026 and petrochemical demand climbing sharply, Indian policy is oriented toward enabling domestic specialty capacity to substitute for imports. That is the opposite of the European posture and explains why the investment is going where it is going.
It is tempting to attribute European deindustrialisation to regulation. The closures radar should restrain that instinct: regulation is the primary rationale in only 8% of announced closures, against 49% for energy cost competitiveness. But the two are not separable. The ETS, renewable levies and network charges are a large part of why European gas costs three times the US benchmark, and the compliance cost of REACH and its successor instruments falls hardest on exactly the producers whose energy costs are already highest.
The net regulatory effect on this forecast is therefore a modest drag concentrated in one region. Europe's 13.0% share of the global market falls to 11.2% by 2033 - a loss of 1.8 percentage points, which is smaller than the capacity closures alone would suggest, because the value of European specialty output per tonne is rising even as the tonnage falls. That is the one place where regulatory pressure is producing a better industry rather than a smaller one.
" faq_question_1: "What is the projected size of the global chemical market by 2033?" faq_answer_1: "According to Phoenix???s Demand Forecast Engine, the global chemical market is expected to expand from USD 6 trillion in 2025 to approximately USD 8.14 trillion by 2033, growing at a CAGR of ~3.81% during the forecast period." faq_question_2: ". Which region dominates the global chemical market?" faq_answer_2: "In 2024, Asia Pacific accounted for the largest share (52.1%) of the global chemical market, driven by strong manufacturing bases in China, India, Japan, and South Korea, along with expanding specialty chemical clusters." faq_question_3: "What is the fastest-growing trend in the global chemical market?" faq_answer_3: "The shift toward green and bio-based chemicals is the fastest-growing trend, fueled by sustainability regulations, renewable feedstock investments, and circular economy initiatives across major regions." faq_question_4: "What are the key drivers of growth in the chemical market?" faq_answer_4: "Major growth drivers include rising industrialization and infrastructure development, demand for specialty and high-performance chemicals, sustainability and green chemistry adoption, and the rise of digital B2B chemical marketplaces." global_schema: organization: "@id": MIWS-root#organization "@type": Organization url: "https://www.pheonixresearch.com/" name: Pheonix Research website: "@id": MIWS-root "@type": WebSite url: "https://www.pheonixresearch.com/" name: Pheonix Research api: "@id": MIWS-root#api "@type": WebAPI url: "https://www.pheonixresearch.com/" graph: node_id: MIMR-node_99ee8d4 graph_node_endpoint: "https://graph.pheonixresearch.com/api/v1/query/live/node/MIMR-node_99ee8d4" graph_snapshot: "https://graph.pheonixresearch.com/api/v1/read/live/graph" graph_exclusions: "https://graph.pheonixresearch.com/api/v1/read/live/exclusions" graph_meta: "https://graph.pheonixresearch.com/api/v1/read/live/meta" graph_bundle: "https://graph.pheonixresearch.com/api/v1/read/live/bundle" discovery: discovery_json: "https://www.pheonixresearch.com/.well-known/pheonix-discovery.json" llms_txt: "https://www.pheonixresearch.com/llms.txt" sitemap: "https://www.pheonixresearch.com/sitemap.xml" --- # Global Chemicals Market Report, Size & Forecast 2025-2033: A USD 5.5 Trillion Industry Growing at 3.3% While 37 Mt of Capacity Leaves ## Market Report ## What this market is, and what USD 5.55 trillion leaves out "Global chemicals" is the least well-defined large number in industrial research. The same calendar year can be reported as a USD 4 trillion market or a USD 9 trillion one without anyone lying, because the boundary is doing all the work. Before any forecast is worth reading, the perimeter has to be stated. This report uses a single, checkable route to the total. Cefic's 2025 Facts and Figures puts European chemical industry turnover at EUR 635 billion and Europe's share of the world chemical market at 13%. Divide one by the other and the implied world market is EUR 4,885 billion. At an average 2025 rate of EUR/USD 1.136 that is **USD 5,549 billion**, rounded here to USD 5,550 billion. The same publication puts China at 46% of global chemical sales, which places Chinese output at roughly USD 2.55 trillion - more than three times Europe's. That perimeter *excludes pharmaceuticals*, and the exclusion is not a technicality. Cefic excludes pharma; the American Chemistry Council's production indices are published "excluding pharma" as a separate line. Bolting pharma back on adds somewhere in the region of USD 1.6 to 1.8 trillion and takes the headline past USD 7 trillion. Adding refined petroleum products takes it past USD 9 trillion. None of those are wrong markets. They are different markets, and a forecast that mixes them cannot be reconciled to anything. The second thing worth stating plainly is that this is not a growth industry in 2025-26, and it has not been for three years. The American Chemistry Council's December 2025 Situation and Outlook puts world chemical output growth at 4.0% in 2024, 2.6% in 2025 and 1.9% in 2026 - a decelerating sequence in which the two forward years are the weakest outside 2020 in the current cycle. Europe contracted 1.2% in 2025 and is forecast to grow 0.2% in 2026. North America grows 1.2% then 0.5%. Only Africa and the Middle East, at 2.3% rising to 3.8%, are accelerating. ## How the 2025 base is built The base is not lifted from a published total. It is the Cefic share calculation above, cross-checked against volume: ACC's world output series implies roughly 2.6% more chemical volume was produced in 2025 than in 2024, and realised prices across the commodity chain were flat to negative. A volume-up, price-down year is what a market carrying structural surplus looks like, and it is why the base here is anchored to a published share calculation rather than to a headline total nobody can check. Two operating facts set the price level. Cefic reports European capacity utilisation 9.5% below its 2014-2019 pre-crisis average. Dow's fourth-quarter 2025 disclosure shows local price down 8% year on year and volume down 2%, with an idled cracker in Europe, the Middle East, Africa and India removing merchant olefin sales from the base. When the marginal tonne is priced by a producer with negative operating leverage, the price index does not recover on demand alone. ## Forecast, 2025-2033 Every growth rate below was computed, not asserted. Value is modelled as volume growth adjusted for a modest price recovery that does not begin in earnest until 2028, once the European closure programme has actually removed tonnes rather than merely announced them. | Scenario | | 2025 (USD bn) | | 2033 (USD bn) | | CAGR | | What has to be true | | **Baseline** | | 5,550.0 | | **7,197.3** | | **3.30%** | | Announced closures complete; China's anti-involution slows but does not stop additions | | Conservative | | 5,550.0 | | 6,788.6 | | 2.55% | | Surplus persists to 2030; price recovery deferred two years | | Optimistic | | 5,550.0 | | 7,683.6 | | 4.15% | | European cracking capacity exits faster than announced and Chinese additions are absorbed | Absolute growth across the window is USD 1,647.3 billion. Asia Pacific supplies **62.7%** of it despite already being 52.0% of the base - the arithmetic consequence of a region growing at 3.9% from a majority position while Europe grows at 1.4% from 13%. ## What is actually driving the number Three forces set the trajectory, and only one of them is demand. **Capacity is leaving the high-cost region.** Cefic and Roland Berger's first European Closures and Investments Radar, published January 2026, counts announced European chemical capacity closures rising sixfold from 2.9 Mt in 2022 to 17.2 Mt in 2025 year-to-date, and roughly doubling in the final year. Cumulative announcements over 2022-25 total 37 Mt, about 9% of European chemical production capacity, affecting approximately 20,000 direct jobs. Half of the petrochemical total is nine steam crackers - a net 16% reduction in European steam cracking capacity. Energy cost competitiveness is cited as the primary rationale in 49% of cases, demand in 19%, overcapacity in 9% and regulation in 8%. German sites account for 8.8 Mt (25%) and Dutch for 7.2 Mt (20%). **Capacity is arriving in the low-cost one.** China is adding a further 7-8 Mtpa of ethylene and roughly 6 Mtpa of polyethylene in 2026, which nets out to more than 4.0 Mtpa of new ethylene and derivatives capacity even after plant closures, according to the announced project schedule. The "anti-involution" policy introduced in July 2024 was meant to discipline this; it has moderated output growth rather than forcing shutdowns. Reuters reported in April 2026 that China's industry ministry and six other departments now intend to upgrade some outdated petrochemical plants and phase others out by 2029, with annual rolling surveys of newly identified facilities from 2027. That is a real policy instrument. It is also a 2029 instrument, and the tonnes are landing in 2026. **Price is the shock absorber.** BASF's 2025 results show sales of EUR 59.7 billion against EUR 61.4 billion, with EBITDA before special items down EUR 686 million to EUR 6.6 billion as contribution margins fell in Chemicals, Industrial Solutions, Materials and Nutrition and Care. Dow's full-year 2025 net sales were USD 40.0 billion with a GAAP net loss of USD 2.4 billion, against income of USD 1.2 billion in 2024, and operating EBIT of USD 0.4 billion against USD 2.6 billion. Neither company lost volume share in any meaningful sense. Both were paid less for the same molecules. That combination - volume up, price down, capacity relocating between regions - produces low single-digit value growth. **3.30% is a position, not a consensus echo.** Any forecast that starts in 2026 and assumes normal mid-cycle pricing inherits a surplus that has not yet cleared; any forecast that assumes the surplus never clears understates the closure programme already signed. ## Regional outlook Regional bases are modelled from the Cefic share data (China 46%, Europe 13%) plus a Pheonix allocation for the remainder. They are estimates, and they are the least independently verifiable numbers on this page. | Region | | 2025 (USD bn) | | Share 2025 | | 2033 (USD bn) | | Share 2033 | | CAGR | | **Asia Pacific** | | 2,886.0 | | 52.0% | | **3,919.4** | | 54.5% | | **3.9%** | | North America | | 860.3 | | 15.5% | | 1,031.9 | | 14.3% | | 2.3% | | Europe | | 721.5 | | 13.0% | | 806.4 | | 11.2% | | 1.4% | | Middle East & Africa | | 527.3 | | 9.5% | | 744.1 | | 10.3% | | 4.4% | | Latin America | | 360.8 | | 6.5% | | 457.0 | | 6.3% | | 3.0% | | Former Soviet Union | | 194.3 | | 3.5% | | 238.5 | | 3.3% | | 2.6% | | **Total** | | **5,550.0** | | 100.0% | | **7,197.3** | | 100.0% | | **3.30%** | Asia Pacific grows 35.8% across the window; Europe grows 11.8%. India is the single fastest-growing large market inside the Asian total - ACC forecasts Indian GDP growth of 6.4% in 2026 and notes Indian producers accelerating specialty capacity investment specifically to reduce import dependence. Africa and the Middle East post the fastest regional rate at 4.4%, from a base one-sixth the size. ## Segment outlook | Segment | | 2025 (USD bn) | | 2033 (USD bn) | | CAGR | | Note | | Basic chemicals and petrochemicals | | 2,331.0 | | 2,862.3 | | 2.6% | | 39.8% of the 2033 total, down from 42.0% | | Specialty chemicals | | 1,498.5 | | 2,035.1 | | 3.9% | | The only large segment where price holds | | Agrochemicals | | 610.5 | | 729.4 | | 2.25% | | ACC world output +5.8% 2025, -0.4% 2026 | | Consumer chemicals | | 499.5 | | 642.7 | | 3.2% | | Volume-linked, low cyclicality | | Bio-based and green chemicals | | 222.0 | | 442.4 | | 9.0% | | 4.0% to 6.1% of the total; small base | | Basic inorganics and other | | 388.5 | | 484.6 | | 2.8% | | 32% of European closures by tonnage | | **Total** | | **5,550.0** | | **7,196.4** | | **3.30%** | | Rounding against the regional total | The single most useful line in that table is the first one. Basic chemicals and petrochemicals are 42.0% of the market today and 39.8% in 2033 - a majority of the tonnage and a shrinking share of the value. Everything the industry calls a strategy is an attempt to move up this table. ## Companion analysis This report is the umbrella. The [global petrochemicals market](https://www.pheonixresearch.com/chemicals-materials/industrial-material/market-report/global-petrochemicals-market/) sizes the upstream block that sits inside it. [Ethylene](https://www.pheonixresearch.com/chemicals-materials/industrial-chemical/market-report/global-ethylene-market-2025-2033/) carries the clearest evidence of the surplus: 235 Mt of nameplate capacity against roughly 190 Mt of demand. [Polypropylene](https://www.pheonixresearch.com/chemicals-materials/industrial-chemical/market-report/global-polypropylene-and-polypropylene-composites-market-2025-2033/) is where Chinese export push shows up first as price. And [Mexico](https://www.pheonixresearch.com/chemicals-materials/industrial-chemical/market-report/mexico-chemicals-market/) is the test case for whether nearshoring can build a chemical base outside Asia. ## What would change the forecast Two variables carry almost all the variance. The first is whether the 37 Mt of announced European closures is completed on schedule; a programme that slips into 2030 moves the price recovery out with it and lands the market on the conservative path. The second is whether China's 2029 phase-out list has teeth. If it does, the surplus clears from both ends at once and 4.15% becomes available. If it does not, 2.6% basic-chemical growth is optimistic, not conservative. ## Table of Contents OverviewWhat USD 5.55 trillion includes and excludes; the perimeter problem The 2025 baseCefic share arithmetic, cross-checked against ACC volume Forecast, 2025-2033Baseline USD 7,197.3bn at 3.30%; conservative and optimistic paths What is actually driving the numberCapacity leaving Europe, arriving in China, and price as the shock absorber Regional outlookAsia Pacific 52.0% to 54.5%; Europe 13.0% to 11.2% Segment outlookBasic chemicals 42.0% to 39.8%; specialty holds price Companion analysisPetrochemicals, ethylene, polypropylene and Mexico What would change the forecastThe two variables that carry the variance Competitive LandscapeWhy no company in this industry has share, and four archetypes that do not compete on the same axis Value ChainA feedstock arbitrage with a service business bolted on Investment ActivityCapex contracting in the West, concentrating in Asia and the Gulf Technology InnovationElectric cracking, circular carbon, and why neither moves the 2033 number Market RiskSurplus, trade defence, energy and the risk that specialty is a label Regulatory LandscapeChemicals are not in CBAM – what actually applies, and from when ## Competitive Landscape No company in this industry has share. That is not a rhetorical flourish; it is the structural fact that determines everything else about how the competitive landscape behaves. BASF, the largest chemical company in the world by revenue outside the Chinese state-owned complex, reported sales of EUR 59.7 billion in 2025. At an average 2025 rate of EUR/USD 1.136 that is USD 67.8 billion, or 1.22% of a USD 5,550 billion market. Dow reported net sales of USD 40.0 billion, or 0.72%. Put the two largest Western chemical companies together and they hold less than two percentage points of the market between them. A top-ten list in this industry accounts for a low single-digit fraction of the whole, and the reason is arithmetic: the market is not a market in the antitrust sense. It is several hundred product markets that happen to share a feedstock base. Concentration in chemicals exists at the product level. In commodity olefins a single world-scale cracker can matter to a regional balance. In a specialty additive, three or four producers can hold most of the supply. But there is no participant whose position in ethylene gives it pricing power in polyurethane catalysts, and no participant whose position in coatings gives it leverage over naphtha. The competitive landscape is therefore not one landscape. It is four, and they do not compete on the same axis. Archetype one: the integrated feedstock owner SABIC, Sinopec, ExxonMobil Chemical, Dow, LyondellBasell, the Gulf national champions and increasingly the large Chinese private refiners. Their position rests on molecule ownership at the wellhead or the refinery gate. They win or lose on feedstock differential and on operating rate, and they are structurally long the commodity end of the chain. Dow’s 2025 numbers show what that means in a down-cycle: operating EBIT of USD 0.4 billion on USD 40.0 billion of sales, a margin of 1.0%, against USD 2.6 billion the year before – a fall of 84.6%. Cash from operations halved to USD 1.1 billion. The company still paid USD 1.5 billion of dividends. This is the archetype most exposed to the capacity wave described elsewhere in this report, and the one with the least room to do anything about it. When Dow idles a cracker in Europe, the Middle East, Africa and India, as it did during 2025, that is not a strategic retreat. It is an admission that the marginal barrel of merchant olefin in that region does not cover cash cost. Archetype two: the European integrated cluster BASF, INEOS, Covestro, Evonik, Clariant, Solvay and the Verbund sites they operate. The defining asset is not a plant but an integration: a cracker whose by-products become the next unit’s feedstock, whose waste heat runs the next unit, and whose logistics are pipelines rather than trucks. Verbund economics are genuinely superior – which is why BASF’s EBITDA before special items margin of 11.1% in 2025 was eleven times Dow’s operating margin on a far more diversified base. But Verbund economics are a defence against operating inefficiency, not against energy price. Cefic’s 2025 Facts and Figures reports European gas prices still three times US levels and capacity utilisation 9.5% below the 2014-2019 pre-crisis average. A Verbund is a machine for turning cheap energy into many products at once; when energy is not cheap, integration multiplies the cost rather than diluting it. BASF’s response is instructive and unromantic. Between December 2023 and December 2025 it cut senior executives by 11% and reduced headcount by roughly 4,800, excluding about 1,000 recruited at the new Zhanjiang site in China over the same period. EUR 937 million of special charges were booked in 2025 for restructuring, primarily for the Ludwigshafen programme. The cluster is being made smaller, not fixed. Archetype three: the Asian national champion Wanhua, Reliance, PTT Global Chemical, Formosa, Hanwha, LG Chem, and behind them the Chinese state-owned majors. Their competitive logic is different again: they are instruments of industrial policy as much as commercial entities, they are financed at a cost of capital no Western peer can match, and their capacity decisions are made partly for strategic reasons. China now accounts for 46% of global chemical sales according to Cefic – roughly USD 2.55 trillion, more than three times Europe’s 13%. This is where the surplus is being manufactured. China is adding 7-8 Mtpa of ethylene and roughly 6 Mtpa of polyethylene in 2026, netting more than 4.0 Mtpa of new ethylene and derivatives capacity even after closures. The evident consequence is already visible in trade flows: Chinese polypropylene imports have fallen sharply from 2020 levels while exports keep rising, and those volumes are reaching North and Southeast Asia, Africa and Latin America. Archetype four: specialty and asset-light DuPont, Croda, the post-divestiture parts of the old ICI and Hoechst inheritance, and a long tail of formulators. These businesses are genuinely differentiated on application knowledge and qualification cycles rather than on molecules, and they are the only archetype earning a defensible margin in the current cycle. The catch is that they are small. Specialty chemicals are 27% of the market in this report’s segmentation and grow at 3.9% – fast enough to take share of value, nowhere near large enough to absorb the capital and people leaving the commodity end. What competition actually looks like in 2026 The competitive variable that matters most is not market share. It is survival of the cost position, and the industry has started to resolve it by exit rather than by price war. Cefic and Roland Berger count 37 Mt of announced European capacity closures over 2022-25, about 9% of the region’s chemical capacity, affecting roughly 20,000 direct jobs. Half of the petrochemical tonnage is nine steam crackers – a net 16% reduction in European cracking capacity. Energy cost competitiveness is cited in 49% of the closure decisions, demand in 19%, overcapacity in 9% and regulation in 8%. That is a competition being settled by balance sheet and by geography, not by product. The companies that win the next five years will be the ones with feedstock advantage in the Gulf and North America, policy support in China and India, or an application franchise defensible enough to price through a surplus. Companies that have none of the three will keep doing what BASF and Dow did in 2025: shrink the asset base, book the charge, and hold the dividend. ## Value Chain The chemical value chain is usually drawn as five boxes: feedstock, cracker, derivatives, formulation, customer. The useful version of that diagram makes a blunter point. From naphtha to polymer pellet, this is a feedstock arbitrage with a service business bolted onto the end. Almost every margin question in the industry reduces to which of those two things a company is actually doing. Stage one: feedstock Two routes dominate. Steam cracking of naphtha produces ethylene and propylene together with a broad slate of C4s, aromatics and pygas; it is flexible in product mix and expensive in energy. Steam cracking of ethane produces mostly ethylene, cheaply, but leaves the cracker with almost nothing else to sell. The choice between them is not technical preference – it is a bet on the relative price of oil and gas that a company then has to live with for twenty years. North American crackers built on shale ethane in the 2010s were built on that bet and won it. European crackers built on naphtha mostly lost it, and Cefic now reports European gas at three times US levels. That single differential, more than any management decision, explains why nine European steam crackers representing a net 16% of the region’s cracking capacity have been announced for closure. The Gulf sits in a third position: associated gas and ethane at a cost that no other region can replicate, with the political economy of a state that wants industrial diversification rather than maximum molecule margin. SABIC’s competitive position is a function of the Saudi feedstock allocation, not of its operating excellence. Stage two: the cracker and the co-product problem A cracker does not make one product. It makes a slate, and the economics of the whole unit depend on what the minor products are worth. Ethylene is the headline; propylene, butadiene, benzene, toluene, xylenes and pygas are the credits that decide whether the unit is profitable. When the C4 and aromatic markets are weak, the ethylene cash cost rises even if ethylene itself is unchanged. This is why integrated complexes beat standalone ones and why the industry’s cost curves are not smooth. It also explains a counterintuitive feature of the current cycle: producers with the most diversified slate are the ones most able to keep running through a trough, because some co-product somewhere is still covering its marginal cost. That is Verbund economics, and it is real. It is also not enough – BASF booked EUR 937 million of restructuring charges in 2025, primarily for Ludwigshafen, despite having the best-integrated site in Europe. Stage three: derivatives and the spread Between the cracker and the customer sit the derivative units – polyethylene, polypropylene, ethylene oxide and glycols, vinyls, styrenics, acrylates, oxo alcohols. This is where the majority of the industry’s tonnage is converted and where the surplus is felt most directly. China’s addition of more than 4.0 Mtpa of net new ethylene and derivatives capacity in 2026 lands almost entirely in this stage, and the effect is a compression of the derivative-to-feedstock spread rather than a fall in volume. Dow’s fourth-quarter 2025 disclosure is the cleanest available measurement of that compression: net sales down 9% year on year, local price down 8%, volume down only 2%. In other words roughly four-fifths of Dow’s revenue decline came from price, not from selling less. For the full year the company reported a GAAP net loss of USD 2.4 billion against income of USD 1.2 billion in 2024, and operating EBIT of USD 0.4 billion against USD 2.6 billion. Stage four: formulation and the service layer Above the derivative units the chain changes character. Formulation – coatings, adhesives, sealants, lubricant additives, personal care actives, crop protection formulations, water treatment programmes – is not an arbitrage on feedstock. It is a service business: technical support, qualification against a customer’s specification, regulatory documentation, and a switching cost measured in months of requalification rather than in dollars per tonne. This is where margin survives. It is also why specialty chemicals, at 27% of this market, grow at 3.9% while basic chemicals and petrochemicals, at 42%, grow at 2.6%. The service layer is not immune to the cycle; it is simply not priced off naphtha. Stage five: distribution Between the producer and the small customer sits a distributor layer that most market reports ignore and that carries a meaningful share of the physical flow – Brenntag, Univar Solutions, Azelis and a long regional tail. Distributors exist because the industry’s customer base is fragmented and its order sizes are not: a formulator buying four drums does not want a producer relationship, and a producer does not want a four-drum order. The distributor’s margin is a logistics and working-capital spread, and it is remarkably stable through the cycle precisely because it is not a molecule margin. Where the value actually accrues The pattern across the whole chain is consistent. Value accrues where the number of substitutes is lowest. That is the feedstock position in the Gulf, the qualification in a formulated specialty, and the specification in a regulated application. It does not accrue in the middle, where a commodity pellet is a commodity pellet and the buyer’s only question is the delivered price of the next 5,000 tonnes. Which is the reason the industry’s strategic language is so uniform. Every announced initiative in this sector – circular feedstocks, bio-based intermediates, low-carbon cracking, digital customer interfaces – is an attempt to move a business out of the middle of this chain and into one of the ends. The 37 Mt of European closures is the same movement performed by subtraction: if you cannot move up the chain, leave it. ## Investment Activity The most consequential number in the chemical industry in 2026 is not a growth rate. It is EUR 1.5 billion. That is the confirmed investment capex in the European chemical industry in 2025 year-to-date, according to Cefic’s and Roland Berger’s first European Closures and Investments Radar. In 2022 the same measure was EUR 7.6 billion. The decline is 80.3% in three years, and confirmed new capacity fell from 2.7 Mt in 2022 to 0.3 Mt in 2025 year-to-date – a fall of 86% in the final year alone. Cumulative confirmed investments across 2022-25 total 7 Mt, roughly 2% of European chemical production capacity, against 37 Mt of announced closures. Read those two figures together and the investment story of this industry writes itself. Europe is not investing in chemicals. It is de-investing, at a ratio of roughly five tonnes of closure for every tonne of new capacity. What the closures are, and what they mean for capital The 37 Mt total is distributed unevenly by segment: upstream petrochemicals 17.8 Mt (48%), basic inorganics 11.7 Mt (32%), polymers 5.4 Mt (15%) and specialty chemicals 2.0 Mt (5%). By country, Germany accounts for 8.8 Mt (25%) and the Netherlands for 7.2 Mt (20%), followed by the UK at 4.5 Mt, France at 3.9 Mt, Italy at 2.5 Mt, Belgium at 2.3 Mt and Spain at 1.6 Mt. Roughly 20,000 direct jobs are cited across the announcements. The geographic concentration matters for how the capital cycle resolves. Germany and the Netherlands are not peripheral sites. They are the two most integrated chemical clusters in Europe, and the nine steam crackers in the closure count sit inside them. When a cracker leaves an integrated cluster, the derivative units around it lose their feedstock pipeline and start buying merchant molecule at merchant prices. Closures inside a Verbund have a multiplier that closures of standalone plants do not, and Cefic’s own framing – that the affected crackers are all located in integrated clusters, putting those clusters under increasing pressure – is unusually direct for an industry association. How the large cap companies are allocating BASF’s 2025 results show the pattern at company level. Capital expenditure including intangibles was EUR 4.3 billion in 2025 and is guided to EUR 3.4 billion in 2026 – a reduction of about a fifth in a single year. Free cash flow nonetheless improved to EUR 1.3 billion from EUR 0.7 billion, and 2026 guidance is EUR 1.5 to 2.3 billion. That is the arithmetic of a company funding itself by spending less, not by earning more: EBITDA before special items fell to EUR 6.6 billion from EUR 7.2 billion. Where BASF is still spending is instructive. The Zhanjiang Verbund site in China was successfully started up during the year, and about 1,000 people were recruited there between December 2023 and December 2025, even as total headcount fell by roughly 4,800. The capital is following the demand, and the demand is in Asia. The company is also systematically unlocking value from standalone businesses – Surface Technologies, Agricultural Solutions, Coatings – which is portfolio monetisation rather than industrial investment. Net special income of EUR 1.3 billion in 2025, mainly Wintershall Dea reimbursements relating to expropriated Russian assets, flattered net income to EUR 1.6 billion and should not be read as operating improvement. Dow’s 2025 was a defensive capital programme rather than an investment one. The company reported having achieved well over half of more than USD 6.5 billion in near-term cash and cost support actions, including accelerated delivery of more than USD 400 million of savings under a USD 1 billion programme. Cash from continuing operations fell to USD 1.1 billion from USD 2.9 billion, and USD 1.5 billion of dividends were still paid. When a company’s capital allocation priority is self-funding a dividend through a trough, growth capex is the residual. Where the growth capital is going Three destinations absorb almost all of the industry’s genuine growth investment. China, despite the policy. China is adding 7-8 Mtpa of ethylene and about 6 Mtpa of polyethylene in 2026, netting more than 4.0 Mtpa of new ethylene and derivatives capacity even after plant closures. The April 2026 programme from the industry ministry and six other departments to upgrade some outdated petrochemical plants and phase out others by 2029 is not a brake on this – it is a quality filter applied after the capacity has been committed. Prior-cycle investment decisions are locked in; policy can only decide which of them survive to 2029. India, on import substitution. The ACC’s 2026 outlook singles out India as the growth driver within Asia Pacific, with GDP growth forecast at 6.4% and petrochemical demand projected to climb sharply – prompting Indian producers to accelerate specialty chemicals capacity specifically to reduce reliance on imports. This is the one large market where new Western-aligned chemical capacity has a structural reason to exist: domestic demand growth plus a policy environment that rewards local supply. The Gulf and North America, on feedstock. Projects here are justified by molecule cost rather than by market growth, and they are the only projects in the world that can underwrite a commodity cracker on a through-cycle basis. They also explain why the global capacity total keeps rising while the Western company capital total keeps falling: the two numbers are measuring different geographies. What European investment is still happening The confirmed European investment that survives is not commodity. Of the capital committed in 2022-25, themes cluster around the battery value chain at EUR 1.9 billion (14%), emission reduction at EUR 1.9 billion (14%) and recycling at EUR 1.5 billion (11%). Belgium took 2.4 Mt (36%) of confirmed capacity, Germany 0.8 Mt (12%) and France 0.4 Mt (6%) – about 60% of the total. That is a coherent picture. Europe is not building chemical capacity; it is building decarbonisation and circularity capability on top of a shrinking chemical base. Whether that is a strategy or a consolation depends entirely on whether the regulatory framework that justifies it survives contact with the competitiveness debate – which is the subject of the Regulatory Landscape section of this report. The investment conclusion Capital in this industry is no longer allocated to markets. It is allocated to cost positions. A company will build in China at Chinese feedstock and labour economics, in the Gulf at Gulf gas economics, and in India at Indian demand economics. It will not build in a region where gas costs three times the US benchmark, utilisation runs 9.5% below its own pre-crisis average, and the policy framework adds cost faster than it adds demand. The EUR 1.5 billion is what that decision looks like when it is counted. ## Technology & Innovation The chemical industry has no shortage of technology narratives. It has a shortage of technologies that change the cost of a tonne. Those are different things, and the gap between them explains why so much announced innovation has so little effect on a forecast. Three frontiers are real, in ascending order of how much they matter to the 2033 number: digital and process intensity, electrified cracking, and circular carbon. Only the first earns money today. Frontier one: process intensity and digital control The least glamorous frontier is also the most reliably profitable. A cracker is a large, continuous, energy-intensive furnace train, and small improvements in yield, run-length between decokes, and energy per tonne of product compound over a whole site. Artificial intelligence applied to process control – inferential sensors, advanced process control, real-time optimisation, predictive maintenance – is now genuinely deployed in this industry rather than piloted, because the payback is measured in months and requires no new molecule. The evidence that this is the live frontier is in the efficiency data rather than the vendor material. Cefic reports the European chemical industry has improved its energy efficiency by 40% since 1990. That improvement was not delivered by a breakthrough technology. It was delivered by thousands of incremental process gains, and it is why European producers can still run at all with gas at three times the US price. There is a strategic implication that gets missed. In a surplus market, the return on a process improvement accrues to the customer, not the producer, because price is set by the marginal cost of the least efficient producer still running. Yield gains raise the industry’s output and lower the industry’s price. That is good for chemical users and largely neutral for chemical makers – which is why process innovation in a trough is defensive rather than growth-generating. Frontier two: electrifying the cracker Steam cracking is the sector’s largest single point-source of CO2 and its hardest to abate, because the reaction heat comes from burning fossil fuel inside the furnace. Electrified cracking replaces the burners with electrically heated reactors, which allows the heat to be decarbonised if the electricity is. The flagship demonstration is the eFurnace developed by BASF, SABIC and Linde, a 6 MW electrically heated steam cracker furnace integrated into an existing Verbund site at Ludwigshafen. Six megawatts is two orders of magnitude below a world-scale cracker, and that is the honest way to read it: the technology has been shown to work at demonstration scale, not at commercial scale, and the economics depend entirely on the price of low-carbon electricity relative to the price of gas. That dependency is the whole story. European industrial electricity prices are not converging on US shale gas economics in this decade. An electrified cracker in a region with three-times-US gas and expensive power converts a feedstock disadvantage into a power disadvantage without removing it. The technology will be deployed first where electricity is cheap and carbon is priced – which, in this decade, means neither Europe nor the United States in volume. Frontier three: circular carbon The most capital-intensive frontier is chemical recycling: breaking plastic waste back to monomers or to a naphtha substitute so that it can be re-cracked. It is the industry’s answer to both the packaging regulation and the reputational problem of plastic, and in 2026 it is still a rounding error in the tonnage. European chemical recycling capacity at the start of 2026 comprises roughly 405,000 tonnes per year across fourteen pilot plants and three commercial facilities. Pyrolysis accounts for about 330,000 tonnes of that, glycolysis about 50,000 and methanolysis about 25,000. The three commercial plants are SABIC’s Geleen unit in the Netherlands at 50,000 tonnes (online 2024), BASF’s ChemCycling plant at Schwarzheide in Germany at 80,000 tonnes (online 2025), and OMV’s ReOil unit in Vienna at 200,000 tonnes – the largest, online in the first quarter of 2026. Pilots include OMV Schwechat, Neste Porvoo, INEOS Cologne and Borealis Stenungsund. Against European polymer production of roughly 55 million tonnes a year, 405,000 tonnes is less than 1%. It is instructive to put it beside mechanical recycling: mechanical PET recycling in the EU alone runs at about 1.8 million tonnes a year, roughly five times the entire chemical recycling total, because it costs 30-40% less and has a better energy balance. Two structural constraints limit how fast this scales. The first is scale economics: chemical recycling needs roughly 50,000 tonnes a year or more at a single site to make sense, which excludes most local and specialty waste streams. The second is what the industry calls the mass balance problem. A plant producing 5,000 tonnes of pyrolysis oil feeds it into a cracker or refinery handling millions of tonnes, and the recycled content has to be allocated across the output by an accounting convention. The convention is defensible; the marketing claim built on it is frequently not. What this means for who earns the margin The forecast in this report puts bio-based and green chemicals at 9.0% CAGR, the fastest segment in the market – and still only 6.1% of the total by 2033, up from 4.0%. That is the honest shape of the technology transition. It grows six times faster than the industry and remains a niche, because it starts from USD 222 billion and the industry starts from USD 5,550 billion. The technologies that will matter to 2033 are not the ones with the best press. They are the ones that change the delivered cost of a tonne in a region that currently cannot compete: cheap low-carbon power for electrified cracking, waste feedstock logistics that work at 50,000 tonnes, and process control that squeezes another few points of yield out of assets already built. Everything else is optionality on a carbon price that does not yet exist at the level required to pay for it. ## Market Risk The risks in this market are unusually easy to rank, because one of them dominates and the others are mostly ways for it to get worse. Structural overcapacity is the risk. Everything below it – trade defence, energy price, feedstock geopolitics, demand substitution – is a mechanism through which the surplus is transmitted into price. Risk one: the surplus is bigger than the demand The clearest measurement sits one step upstream in ethylene, where nameplate capacity is around 235 Mt against roughly 190 Mt of demand – a structural surplus of about 45 Mt, or roughly 19% of capacity. That is not a temporary cyclical gap. It is the arithmetic result of a decade of investment decisions in China, the Gulf and North America arriving at the same time as demand growth decelerated. And it is still growing. China is adding a further 7-8 Mtpa of ethylene and roughly 6 Mtpa of polyethylene in 2026, netting more than 4.0 Mtpa of new ethylene and derivatives capacity even after plant closures. The “anti-involution” policy introduced in July 2024 was designed to discipline exactly this, and it has moderated output growth without forcing shutdowns. The April 2026 plan by the industry ministry and six other departments to upgrade some outdated plants and phase others out by 2029 is a serious instrument – but it is a 2029 instrument, and the tonnes are landing in 2026. The transmission is straightforward. A surplus is cleared by price, and price in chemicals is set at the marginal cash cost of the producer with the lowest feedstock advantage. European and North American producers with naphtha or imported-ethane economics are the marginal producer. They pay for the surplus in margin, which is what BASF’s EUR 686 million fall in EBITDA before special items and Dow’s USD 2.2 billion fall in operating EBIT actually are. Risk two: trade policy has become a pricing input 2025 was the year the chemical industry stopped being able to model trade. The ACC reports that US chemical exports fell 2.0% in 2025 and are expected to fall a further 0.6% in 2026, while imports fell 4.4% to USD 129 billion and are expected to decline another 1.6%. Both are forecast to rebound in 2027 and 2028. The mechanism is visible in the annual profile. ACC describes a burst of activity in the first part of 2025 from front-loading ahead of tariff announcements, followed by a dissipation of momentum as tariff uncertainty generated customer hesitation and inventories built up. US chemical production was up 3.2% year on year in the first quarter and finished the year up only 0.7%. That is a policy shock wearing the costume of a demand shock. The second-order risk is trade defence. As Chinese polypropylene and polyethylene exports reach North and Southeast Asia, Africa and Latin America, the destination markets respond with anti-dumping actions. Each action raises the landed cost of the marginal tonne in that market while doing nothing about the global surplus, so the tonne moves to the next open market. The industry’s protection is localised; its overcapacity is not. Risk three: energy cost is now the deciding variable in Europe Cefic reports European gas prices still three times US levels, and European capacity utilisation 9.5% below its 2014-2019 pre-crisis average. In the closures radar, energy cost competitiveness is cited as the primary rationale in 49% of closure decisions – more than twice the combined weight of demand (19%), overcapacity (9%) and regulation (8%). This is the risk that has already materialised rather than the one to watch. Thirty-seven megatonnes of announced European closures, nine steam crackers and roughly 20,000 direct jobs are the realised loss. The forward risk is that the programme is incomplete: closures inside integrated clusters remove a pipeline, and the derivative units around a departed cracker become structurally uncompetitive even though nobody announced their closure. Some of the next wave will arrive without a press release. Risk four: feedstock geopolitics Chemical margins are a spread, and both legs of the spread can move for reasons unrelated to chemicals. The 2025 Middle East escalation demonstrated the upper bound: Asian ethylene moved from roughly USD 702 per tonne in February to about USD 1,500 per tonne in late March as shipping through Hormuz was disrupted. That is a doubling of the feedstock leg in six weeks, and no producer can hedge it fully. The opposite leg is exposed too. The US ethane export system that supplies European and Asian crackers is a small number of terminals and a single basin; a constraint there is a direct constraint on the operating rate of every ethane-based cracker outside the United States. And because the marginal producer sets the price, a feedstock squeeze harms the efficient producer’s customers as well as the inefficient producer’s margin. Risk five: specialty chemicals may be a label rather than a moat The industry’s answer to commodity surplus is to become specialty. The 2025 data should make anyone cautious about how durable that is. ACC reports US specialty chemical output up 4.3% in 2025 – then forecasts it down 0.2% in 2026, with coatings slowing from 8.4% growth to 0.4%. A category that swings from +4.3% to -0.2% in one year is tracking its customers’ inventory cycle, not earning a structural premium. The distinction that matters is qualification, not marketing. An additive that is written into a customer’s specification has a switch cost. A “specialty” surfactant sold into a formulator that can requalify in six weeks does not. Only the first is a moat, and the industry consistently counts both as one. Risk six: end-market concentration in a narrow set of customers More than 80% of basic and specialty chemicals are consumed by the industrial sector, so the industry’s fortunes are largely the industrial production outlook wearing a different hat. In the US, ACC tracked growth in only nine of its 20 key chemistry end-use industries in 2025, with improvement to twelve expected in 2026. Automotive – where the average vehicle contains more than USD 4,400 of chemistry – is expected to see slightly lower US sales in 2026, and housing is expected to stay flat. A market whose two largest end-use blocks are flat-to-down cannot generate the volume growth needed to absorb new capacity. That is the connection between the demand chapter and the price chapter, and it is the reason this report’s baseline is 3.30% rather than the mid-single-digit rates that appear in vendor material. What the risk set is worth in the forecast The conservative path in this report – USD 6,788.6 billion by 2033 at 2.55% – is not a stress case. It is the baseline with the surplus clearing two years later than assumed, which is what happens if the European closure programme slips and China’s 2029 phase-out list goes unenforced. That single deferral is worth USD 408.7 billion of 2033 value. The realistic downside is larger still, because a deferred recovery also defers the capital that would have been reinvested. ## Regulatory Landscape The single most important regulatory fact about the global chemical industry in 2026 is a negative one. Chemicals are not in CBAM. That statement is worth making explicitly because a great deal of material in this sector assumes the opposite. The Carbon Border Adjustment Mechanism’s definitive regime applies from 1 January 2026, and its covered sectors are cement, iron and steel, aluminium, fertilisers, electricity and hydrogen. Organic chemicals, polymers and specialty chemicals – the overwhelming majority of the USD 5,550 billion market sized in this report – are outside the mechanism entirely. What CBAM actually does, and from when Under the definitive regime, EU importers above a single mass-based threshold of 50 tonnes of CBAM goods must apply for the status of authorised CBAM declarant and buy CBAM certificates from the competent authority in their member state. The certificate price is set from the auction price of EU Emissions Trading System allowances, expressed in euro per tonne of CO2, calculated as a quarterly average during 2026 and a weekly average from 2027 onward. Importers declare embedded emissions and surrender certificates annually, and can deduct any carbon price already paid during production. The regime was simplified and strengthened ahead of go-live by Regulation (EU) 2025/2083, which amended the original Regulation (EU) 2023/956. Its function is to replace the carbon leakage protection that covered sectors currently receive through free allocation of ETS allowances: as free allocation is phased out for steel, cement and aluminium producers, importers surrender correspondingly more certificates. For a chemical company the exposure is therefore indirect but not trivial. Fertilisers are in scope, which captures ammonia and nitric acid production – a real product line for several European chemical majors. CBAM also interacts with electricity and hydrogen pricing, both inputs to chemical production. But the deliberate asymmetry is the point: a European steel producer faces a carbon cost that its import competitor also faces. A European cracker operator faces the ETS cost and its Middle Eastern or Chinese competitor faces nothing. That asymmetry, not the absolute cost of carbon, is the industry’s strongest policy complaint. It is also the reason the Commission’s review of CBAM’s scope is watched more closely in Ludwigshafen and Antwerp than in Brussels: extension to organic chemicals would remove the distortion, and extension would also raise the cost of every downstream European manufacturer that uses imported chemistry. REACH, restriction workload and the simplification turn Inside Europe the binding constraint is not carbon, it is authorisation. REACH’s registration, evaluation, authorisation and restriction machinery sets the cost of keeping a molecule on the market, and the direction of travel over the past five years has been toward broader, group-based restrictions rather than substance-by-substance decisions. The clearest live example is the universal restriction proposal for per- and polyfluoroalkyl substances, which would cover a very large substance group across industrial uses including fluoropolymers, semiconductor processing and refrigerants. For a chemical producer, a group restriction of that breadth is not a compliance cost – it is a portfolio question, because the substitution work has to be done years before the restriction applies. Against that, the Commission has moved REACH revision into a wider simplification agenda aimed explicitly at reducing reporting burden and shortening approval timelines. The two forces are pulling in opposite directions and both are real: the same administration is producing more restriction proposals and fewer administrative obligations. Companies should budget for the first and not bank on the second. Packaging law is now a chemical demand driver The Packaging and Packaging Waste Regulation, Regulation (EU) 2025/40, sits outside the chemical regulatory perimeter but has become one of its more consequential demand signals. Recycled-content obligations for packaging create a legislated market for recycled polymer, which is the commercial justification for the chemical recycling capacity discussed in the Technology Innovation chapter. When a regulation creates demand rather than removing supply, it is the only kind of environmental rule the industry actively lobbies for. The regulatory picture outside Europe China. The regulatory lever is industrial rather than environmental in effect. The April 2026 programme from the industry ministry and six other departments will upgrade some outdated petrochemical plants and phase out others by 2029, using lists compiled by local governments, with annual rolling surveys of newly identified facilities from 2027. Separately, authorities plan to reduce oil refining capacity to bring the petrochemical supply-demand balance back into line. These are the most consequential chemical regulations in the world in the 2026-2030 window, and they are being written in Beijing rather than Brussels. United States. The dominant regulatory variable is trade policy rather than chemical law. The ACC’s own framing is that the US industry risks losing its competitive advantage through “unfair import competition and overregulation” – a statement that positions the trade and environmental agendas as one issue. TSCA administration continues, but the binding constraint on US chemical investment in this cycle is tariff uncertainty, not registration. India. The regulatory agenda is expansionary. With GDP growth forecast at 6.4% in 2026 and petrochemical demand climbing sharply, Indian policy is oriented toward enabling domestic specialty capacity to substitute for imports. That is the opposite of the European posture and explains why the investment is going where it is going. What the regulation is actually worth It is tempting to attribute European deindustrialisation to regulation. The closures radar should restrain that instinct: regulation is the primary rationale in only 8% of announced closures, against 49% for energy cost competitiveness. But the two are not separable. The ETS, renewable levies and network charges are a large part of why European gas costs three times the US benchmark, and the compliance cost of REACH and its successor instruments falls hardest on exactly the producers whose energy costs are already highest. The net regulatory effect on this forecast is therefore a modest drag concentrated in one region. Europe’s 13.0% share of the global market falls to 11.2% by 2033 – a loss of 1.8 percentage points, which is smaller than the capacity closures alone would suggest, because the value of European specialty output per tonne is rising even as the tonnage falls. That is the one place where regulatory pressure is producing a better industry rather than a smaller one. ## Frequently Asked Questions **Q: What is the projected size of the global chemical market by 2033?** According to Phoenix???s Demand Forecast Engine, the global chemical market is expected to expand from USD 6 trillion in 2025 to approximately USD 8.14 trillion by 2033, growing at a CAGR of ~3.81% during the forecast period. **Q: . Which region dominates the global chemical market?** In 2024, Asia Pacific accounted for the largest share (52.1%) of the global chemical market, driven by strong manufacturing bases in China, India, Japan, and South Korea, along with expanding specialty chemical clusters. **Q: What is the fastest-growing trend in the global chemical market?** The shift toward green and bio-based chemicals is the fastest-growing trend, fueled by sustainability regulations, renewable feedstock investments, and circular economy initiatives across major regions. **Q: What are the key drivers of growth in the chemical market?** Major growth drivers include rising industrialization and infrastructure development, demand for specialty and high-performance chemicals, sustainability and green chemistry adoption, and the rise of digital B2B chemical marketplaces.